Steroid study seeks clues to prevent preemie lung disease

NCT ID NCT01854840

First seen Mar 08, 2026 · Last updated Jun 09, 2026 · Updated 17 times

Summary

This study looked at how a steroid called betamethasone, given to pregnant women to help their babies' lungs, moves from mother to baby. Researchers wanted to see if the amount that reaches the baby affects the risk or severity of hyaline membrane disease, a serious breathing problem in premature newborns. The study included 127 pregnant women and their babies. The goal was to better understand how this medicine works, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYALINE MEMBRANE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Necker Hospital

    Paris, 75015, France

Conditions

Explore the condition pages connected to this study.

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.